Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19


Satış H., Özger H. S. , Aysert Yıldız P., Hızel K., Gulbahar Ö. , Erbaş G., ...Daha Fazla

CYTOKINE, cilt.137, 2021 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Background: The effectual immune response is crucial to defeat viral infections. However, exuberant immune response with features of macrophage activation syndrome (MAS) lead detrimental consequences in COVID-19 patients. Interleukin (IL)-18 is one of the leading cytokines in MAS which has not been studied in COVID-19.